PROM1 and lung carcinoma: The role of CD133 as a CSC marker has, however, been questioned, for example, using the lung cancer cell lines A549 and H446, where more than 45% of the cells represent bona-fide CSC, it has been reported that both CD133+ and CD133− cells are able to form tumors with the same efficiency (29).